|
Gorog DA, Gue YX, Chao TF, Fauchier L, Ferreiro JL, Huber K, Konstantinidis SV, Lane DA, Marin F, Oldgren J, Potpara T, Roldan V, Rubboli A, Sibbing D, Tse HF, Vilahur G, Lip GYH. Assessment and Mitigation of Bleeding Risk in Atrial Fibrillation and Venous Thromboembolism: Executive Summary of a European and Asia-Pacific Expert Consensus Paper. Thromb Haemost. 2022 Oct;122(10):1625-1652. doi: 10.1055/s-0042-1750385. Epub 2022 Jul 6. PubMed PMID: 35793691.
AÑO: 2022; IF: 6.7
|
35793691
|
Rivera-Caravaca JM, Ding WY, Marin F, Roldan V, Lip GYH; Christina J.-Y. Lee MD, PhD; Christian Torp-Pedersen MD, DMSc. Prediction of ischemic stroke in different populations: a comparison of absolute stroke risk and CHA2DS2-VASc in real-world and clinical trial patients. Eur J Intern Med. 2022 Apr;98:122-124. doi: 10.1016/j.ejim.2021.12.014. Epub 2021 Dec 21. No abstract available. PubMed PMID: 34952769.
AÑO: 2022; IF: 8.0
|
|
Rivera-Caravaca JM, Lip GYH, Roldan V, Marin F. Editorial: New horizons in the management of patients with atrial fibrillation: Interactions with the gastrointestinal system. Front Cardiovasc Med. 2022 Oct 17;9:1042728. doi: 10.3389/fcvm.2022.1042728. eCollection 2022. No abstract available. PubMed PMID: 36324744; PubMed Central PMCID: PMC9619039.
AÑO: 2022; IF: 3.6
|
|
Ding WY, Rivera-Caravaca JM, Shantsila A, Marin F, Gupta D, Roldan V, Lip GYH. Outcomes in VKA-treated patients with atrial fibrillation and chronic kidney disease: Clinical trials vs 'real-world'. Int J Clin Pract. 2021 Apr;75(4):e13888. doi: 10.1111/ijcp.13888. Epub 2020 Dec 15. PubMed PMID: 33283377.
AÑO: 2021; IF: 3.149
|
|
Sanchez-Fuentes A, Rivera-Caravaca JM, Lopez-Galvez R, Marin F, Roldan V. Non-vitamin K Antagonist Oral Anticoagulants and Drug-Food Interactions: Implications for Clinical Practice and Potential Role of Probiotics and Prebiotics. Front Cardiovasc Med. 2022 Jan 17;8:787235. doi: 10.3389/fcvm.2021.787235. eCollection 2021. PubMed PMID: 35111826; PubMed Central PMCID: PMC8801490.
AÑO: 2021; IF: 5.846
|